| 000 | 01574 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513110348.0 | ||
| 264 | 0 | _c19970124 | |
| 008 | 199701s 0 0 eng d | ||
| 022 | _a0022-2623 | ||
| 024 | 7 |
_a10.1021/jm960486n _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDillard, R D | |
| 245 | 0 | 0 |
_aIndole inhibitors of human nonpancreatic secretory phospholipase A2. 2. Indole-3-acetamides with additional functionality. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _cDec 1996 |
||
| 300 |
_a5137-58 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aCrystallography, X-Ray |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndoleacetic Acids _xchemistry |
| 650 | 0 | 4 | _aMagnetic Resonance Spectroscopy |
| 650 | 0 | 4 | _aMass Spectrometry |
| 650 | 0 | 4 |
_aPhospholipases A _xantagonists & inhibitors |
| 650 | 0 | 4 | _aPhospholipases A2 |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aBach, N J | |
| 700 | 1 | _aDraheim, S E | |
| 700 | 1 | _aBerry, D R | |
| 700 | 1 | _aCarlson, D G | |
| 700 | 1 | _aChirgadze, N Y | |
| 700 | 1 | _aClawson, D K | |
| 700 | 1 | _aHartley, L W | |
| 700 | 1 | _aJohnson, L M | |
| 700 | 1 | _aJones, N D | |
| 700 | 1 | _aMcKinney, E R | |
| 700 | 1 | _aMihelich, E D | |
| 700 | 1 | _aOlkowski, J L | |
| 700 | 1 | _aSchevitz, R W | |
| 700 | 1 | _aSmith, A C | |
| 700 | 1 | _aSnyder, D W | |
| 700 | 1 | _aSommers, C D | |
| 700 | 1 | _aWery, J P | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 39 _gno. 26 _gp. 5137-58 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm960486n _zAvailable from publisher's website |
| 999 |
_c8970468 _d8970468 |
||